Dr. Hou Fanfan
侯凡凡
Professor; Chief Physician; Academician of the Chinese Academy of Sciences; Director of the National Clinical Research Center for Kidney Disease (Nanfang Hospital site); Doctoral Supervisor
Where they practice, who they consult.
- Nanfang Hospital, Southern Medical University, Guangzhou
- 40+ years in nephrology
- Mandarin, English
What they personally lead.
Training and recognition
Elected Academician of the Chinese Academy of Sciences for clinical research showing benralisumab/ARB-based regimens slow CKD progression in advanced disease; her landmark trial on benazepril in advanced chronic kidney disease (NEJM 2006) reshaped global guidance on RAAS inhibitors in stage 4 CKD; led multiple national-cohort studies on diabetic kidney disease and cardiovascular outcomes in Chinese CKD patients; recipient of the National Science and Technology Progress Award (Second Prize); published in NEJM, JAMA, and JASN
What to expect
Dr. Hou's clinic is a strong choice for international patients with diabetic kidney disease, advanced (stage 3b–4) CKD, or complex hypertension-CKD overlap. Nanfang Hospital co-hosts the National Clinical Research Center for Kidney Disease (alongside the Jinling site) and offers integrated cardio-renal evaluation. Foreign patients should request the international medical office for scheduling and bring full HbA1c, eGFR, and proteinuria trends.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Hou Fanfan's background to other specialists in Guangzhou. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.